AAP 2022 Hyperbilirubinemia management guidelines
Calculator and clinical decision support for the AAP 2022 guidelines for the management of hyperbilirubinemia in newborns 35 or more weeks of gestation.
Features
- Neurotoxicity risk factors absent, present, or both
- Plot multiple time points to assess trends
- Original and easier to interpret custom plots
- Zoomed in and full 0-336 hour plots
- Phototherapy discontinuation decision support
- Post-discharge follow-up decision support
- Rate of increase between last two measurements
- Flags when TcB should be confirmed with TSB
- Calculate age from times of birth and measurement
(Comparison of AAP 2004 and 2022 thresholds)
(Tool for previous AAP 2004 bili guidelines)
(API access for EHR integration)
Optional age calculator | |
Date of birth | |
Date of measurement | |
Usage Notes
- Can leave bilirubin blank to view thresholds
- Enter a comma-separated list of ages and bilirubin levels to assess trends
- Management recommendations will be based on the latest age
Neurotoxicity Risk Factors
- albumin < 3 g/dL
- isoimmune hemolytic disease
- G6PD deficiency
- other hemolytic conditions
- sepsis
- clinical instability in previous 24 hours
- (prematurity accounted for by distinct threshold curves)
Based on
- Clinical Practice Guideline Revision: Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation. Pediatrics 2022;150(3):e2022058859 [Full text] [PubMed]
- Selected Tables and Figures
- Risk factors for hyperbilirubinemia
- Hyperbilirubinemia neurotoxicity risk factors
- Approach to escalation of care
- Post-discharge follow-up for infants who have not received phototherapy
- Many thanks to Alex Kemper and Thomas Newman for helpful feedback